Bulletin
Investor Alert

Rigel Pharmaceuticals Inc.

NAS: RIGL

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 24, 2021, 6:08 p.m.

/zigman2/quotes/207222917/composite

$

3.79

Change

+0.05 +1.34%

Volume

Volume 5,057

Quotes are delayed by 20 min

/zigman2/quotes/207222917/composite

Previous close

$ 3.89

$ 3.74

Change

-0.15 -3.86%

Day low

Day high

$3.74

$3.91

Open

52 week low

52 week high

$2.22

$5.50

Open

Annual Financials for Rigel Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 20.38M4.48M44.51M59.29M108.62M
Cost of Goods Sold (COGS) incl. D&A --881,000906,000895,000
COGS excluding D&A --287,000223,000189,000
Depreciation & Amortization Expense 941,000465,000594,000683,000706,000
Depreciation 941,000465,000594,000683,000706,000
Amortization of Intangibles -----
Gross Income --43.63M58.38M107.73M
20162017201820192020 5-year trend
SG&A Expense 83.41M83.64M116.31M127.47M136.7M
Research & Development 63.45M46.27M46.9M52.89M60.1M
Other SG&A 19.97M37.37M69.41M74.59M76.6M
Other Operating Expense -----
Unusual Expense 5.77M----
EBIT after Unusual Expense (69.74M)----
Non Operating Income/Expense 88,000732,000---
Non-Operating Interest Income 437,000892,0002.2M2.53M582,000
Equity in Affiliates (Pretax) -----
Interest Expense ---335,0001.35M
Gross Interest Expense ---335,0001.35M
Interest Capitalized -----
Pretax Income (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
Minority Interest Expense -----
Net Income (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
Preferred Dividends -----
Net Income Available to Common (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
EPS (Basic) (0.73)(0.62)(0.44)(0.40)(0.18)
Basic Shares Outstanding 94.39M126.32M160.53M167.4M168.75M
EPS (Diluted) (0.73)(0.62)(0.44)(0.40)(0.18)
Diluted Shares Outstanding 94.39M126.32M160.53M167.4M168.75M
EBITDA (63.03M)(79.15M)(72.09M)(68.41M)(28.27M)
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.